Leading Tourette Syndrome Expert Professor Stephen Jackson invited to talk about Neupulse’s Research and Tourette Syndrome at different November events

    
November 22, 2023

This month, Neupulse has the honour of announcing that our Chief Scientific Officer, Professor Stephen Jackson, recognised as one of the foremost experts in the field of Tourette Syndrome, has been invited to discuss our transformative research at several esteemed events as well as shedding light on the latest advancements in understanding Tourette Syndrome.

Event Highlights:

  • 10th November: Professor Jackson was invited to talk at the Midlands Neurology Society about the latest findings in the field of Tourette Syndrome including Neupulse research.
  • 15th November: Professor Jackson was invited to talk at the Norsk Tourette Forening (Norwegian Tourette’s group) about Neupulse research.
  • 22nd November: The Federation of European Societies for Neuropsychology welcomes Professor Jackson to contribute his expertise in a webinar focusing on the neuropsychology of involuntary movements a cornerstone of Tourette syndrome research.

These invitations underscore the international recognition of Professor Jackson's significant contributions to the field and Neupulse's role in pioneering research that promises to enhance the current treatment of Tourette Syndrome.

Company number: 13198315 

Registered Office:
The Ingenuity Centre
University Of Nottingham Innovation Park
Triumph Road
Nottingham 
England
NG7 2TU

Tourettes Friendly Organisation
All members of the Neurotherapeutics team have completed training with Tourettes Action educating them about Tourettes Syndrome, thus have been awarded with the Tourettes Friendly Organisation badge recognised by Tourettes Action.

Privacy Notice       Cookies

Neupulse and Neutrack are registered trade marks of Neurotherapeutics Ltd

Website by Clifton Media

Back to Top
crossmenu